Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,738 | 158,708 | 131,490 | 195,620 | 190,404 |
| Marketable Securities | N/A | N/A | N/A | 2,180 | 12,393 |
| Receivables | 798 | 10,532 | 30,501 | 5,388 | 12,479 |
| Other current assets | 0 | 0 | 0 | 0 | 13 |
| TOTAL | $127,072 | $175,466 | $167,912 | $208,142 | $223,622 |
| Non-Current Assets | |||||
| PPE Net | 3,727 | 5,091 | 6,835 | 10,400 | 7,599 |
| Other Non-Current Assets | 140 | 140 | 0 | 0 | 0 |
| TOTAL | $3,867 | $5,231 | $6,835 | $10,400 | $7,599 |
| Total Assets | $130,939 | $180,697 | $174,747 | $218,542 | $231,221 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 61 | 160 | 232 | 571 | 157 |
| Accounts payable and accrued liabilities | 555 | 9,256 | 22,883 | 3,661 | 2,412 |
| Accrued Expenses | 8,139 | 12,467 | 14,309 | 8,761 | 9,367 |
| TOTAL | $8,847 | $22,031 | $37,905 | $14,840 | $25,021 |
| Non-Current Liabilities | |||||
| Long Term Debt | 43 | N/A | 285 | 368 | 941 |
| Deferred Revenues | 92 | 148 | 481 | 988 | 13,050 |
| Other Non-Current Liabilities | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 |
| TOTAL | $6,949 | $7,109 | $7,376 | $7,928 | $9,264 |
| Total Liabilities | $15,796 | $29,140 | $45,281 | $22,768 | $34,285 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,141 | 4,128 | 3,246 | 3,206 | 3,164 |
| Common Shares | 373 | 372 | 292 | 288 | 280 |
| Retained earnings | -291,012 | -237,459 | -165,508 | -80,353 | -39,960 |
| Other shareholders' equity | -417 | -142 | 147 | 229 | -222 |
| TOTAL | $115,143 | $151,557 | $129,466 | $195,774 | $196,936 |
| Total Liabilities And Equity | $130,939 | $180,697 | $174,747 | $218,542 | $231,221 |